Response to Measles, Mumps, and Rubella Revaccination in HIV-Infected Children with Immune Recovery after Highly Active Antiretroviral Therapy | Zendy

Linda Aurpibul | Zendy; Thanyawee Puthanakit | Zendy; Thira Sirisanthana | Zendy; Virat Sirisanthana | Zendy

Open Access

Response to Measles, Mumps, and Rubella Revaccination in HIV-Infected Children with Immune Recovery after Highly Active Antiretroviral Therapy

Author(s) -

Linda Aurpibul,

Thanyawee Puthanakit,

Thira Sirisanthana,

Virat Sirisanthana

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/520651

Subject(s) - medicine , rubella , measles , mmr vaccine , vaccination , immunology , measles mumps rubella vaccine , antibody , rubella vaccine , immune system , measles vaccine , virology

The low prevalence of measles antibody in human immunodeficiency virus (HIV)-infected children after immune recovery as a result of highly active antiretroviral therapy increases the risk of morbidity and mortality from disease. The objective of our study was to evaluate the efficacy and safety of revaccination with measles, mumps, and rubella (MMR) vaccine in HIV-infected children with immune recovery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research